About this episode
23andMe CEO Anne Wojcicki talks with Recode's Kara Swisher in this live interview recorded at the Rock Health Summit in San Francisco. In this episode: (01:30) Elizabeth Warren's heritage and disputed science; (08:10) 23andMe's business and the FDA under Trump; (12:09) The impact of Theranos' implosion; (14:24) The challenges of the consumer market and health analysis; (18:40) Privacy, consent and safety; (24:57) Techlash and being "lumped in"; (29:59) Anti-aging technology; (32:23) Partnering with GSK, solving cold cases and ethics; (37:40) Insurance companies and what Wojcicki wished she knew at the start; (39:20) Diversity and going public
Learn more about your ad choices. Visit podcastchoices.com/adchoices
Get every episode summarized
Each time Decoder with Nilay Patel publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Decoder with Nilay Patel
How Sonos rebooted itself
Decoder with Nilay Patel
Sep 3, 20261:13:44completed
New York Governor Kathy Hochul thinks AI should be ‘less evil’
Decoder with Nilay Patel
Aug 31, 202651:10pending
OpenAI's executive exodus has one big winner
Decoder with Nilay Patel
Aug 27, 202640:40pending
How GoFundMe became America's backup plan
Decoder with Nilay Patel
Aug 24, 20261:17:44pending